Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

AIM stock hub

AIM ImmunoTech Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

AIMis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.8M

NYSEAMERICAN

Market data

Live price

Current market quote for this ticker.

Current price

AIM

In the news

Latest news · AIM

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROEn/a

P25 -105.6P50 -46.5P75 -3.1

ROICn/a

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All AIM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

193

Groups with data

Currency

USD

Showing 193 of 193 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000946644
Company name	AIM ImmunoTech Inc.
Country	United States
Country code	US
Cusip	00901B105
Employees	21
Employees Change	-2%
Employees Change Percent	-8.7
Enterprise value	$4.6M
Exchange	NYSEAMERICAN
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US00901B3033
Last refreshed	2026-05-10
Market cap	$2.8M
Market cap category	Nano-Cap
Price	$0.34
Price currency	USD
Rev Per Employee	4,190.48x
Sector	Healthcare
Sic	2836
Symbol	AIM
Website	https://aimimmuno.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-506.99%
EV/Sales	52.3x
FCF yield	-397.98%
P/S ratio	31.29x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	-45.45%
Gross Profit	$-40,000
Net Income	$-14M
Net Income Growth Quarters	2%
Net Income Growth Years	2%
Pretax Margin	-15,861.36%
Profit Per Employee	$-664,667
ROA	-101.3
Roa5y	-59.81
ROCE	2,638.9

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-62.66%
Cagr15y	-52.75%
Cagr1y	-96.89%
Cagr20y	-48.09%
Cagr3y	-80.95%
Cagr5y	-72.29%
EPS Growth Quarters	2
EPS Growth Years	2
Revenue Growth	-48.24x
Revenue Growth Q	-53.33x
Revenue Growth Years	0x
Revenue Growth3 Y	-14.54x
Revenue Growth5 Y	-11.6x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.01
Assets	$5.8M
Cash	$3M
Current Assets	$3.3M
Current Liabilities	$6.2M
Debt	$4.9M
Equity	$-9.8M
Interest Coverage	-14.36
Liabilities	$15.6M
Long Term Assets	$2.5M
Long Term Liabilities	$9.3M
Net Cash	$-1.8M
Net Cash By Market Cap	$-67.16
Tangible Book Value	$-11.4M
Tangible Book Value Per Share	$-3.73
WACC	12.37

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.53
Net Working Capital	$-2.2M
Quick ratio	0.49
Working Capital	$-2.9M
Working Capital Turnover	$-0.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-188.95%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.99%
1Y total return	-96.88%
200-day SMA	1.69
3Y total return	-99.31%
50-day SMA	0.63
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.84%
All Time High	1,002,199.6
All Time High Change	-100%
All Time High Date	2000-03-02
All Time Low	0.33
All Time Low Change	1.62%
All Time Low Date	2026-05-08
ATR	0.08
Beta	1.24
Beta1y	0.83
Beta2y	1.21
Ch YTD	-70.07
High	0.38
High52	20.33
High52 Date	2025-07-28
High52ch	-98.34%
Low	0.33
Low52	0.33
Low52 Date	2026-05-08
Low52ch	1.62%
Ma50ch	-46.78%
Premarket Change Percent	-34.8
Premarket Price	$0.37
Premarket Volume	762,947
Price vs 200-day SMA	-79.97%
RSI	29.99
RSI Monthly	24.65
RSI Weekly	27.03
Sharpe ratio	-1.67x
Sortino ratio	-2.28
Total Return	-188.95%
Tr YTD	-70.07
Tr15y	-100%
Tr1m	-38.18%
Tr1w	-34.43%
Tr3m	-70.36%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-1.08
Operating Income	$-11.7M
Operating margin	-13,254.5
Price target	$10
Price Target Change	$2,859

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	7,988,773%
Float Percent	98.05%
Net Borrowing	2,090,000
Shares Insiders	1.95%
Shares Institutions	1.71%
Shares Out	8,147,782
Shares Qo Q	37.65%
Shares Yo Y	188.95%
Short Float	3.11%
Short Ratio	0.03
Short Shares	3.05

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-11M
Average Volume	812,900.05x
Bv Per Share	-3.19
Ch10y	-99.99
Ch15y	-100
Ch1m	-38.18
Ch1w	-34.43
Ch1y	-96.88
Ch20y	-100
Ch3m	-70.36
Ch3y	-99.31
Ch5y	-99.84
Ch6m	-79.86
Change	-39.66%
Change From Open	-6.14
Close	0.56
Days Gap	-35.71
Depreciation Amortization	210,000
Dollar Volume	1,119,818.8
Earnings Date	2026-03-27
Earnings Time	bmo
EBIT	$-11.7M
EBITDA	$-11.5M
EPS	$-8.62
F Score	3
FCF	$-11M
FCF EV Yield	-238.09x
FCF Per Share	$-1.34
Financing CF	10,388,000
Fiscal Year End	December
Founded	1,966
Investing CF	1,853,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-27
Last Report Date	2025-12-31
Last Split Date	2026-01-09
Last Split Type	Forward
Last10k Filing Date	2026-03-27
Ma150	1.26
Ma150ch	-73.16%
Ma20	0.52
Ma20ch	-34.45%
Net CF	1,284,000
Open	0.36
Optionable	No
Position In Range	12.65
Ppne	449,000
Pre Close	0.56
Price Date	2026-05-08
Relative Volume	4.08x
Revenue	88,000x
SBC By Revenue	68.18x
Share Based Comp	60,000
Tr20y	-100%
Tr6m	-79.87%
Us State	Florida
Volume	3,314,054
Z Score	-113.7

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does AIM pay a dividend?

Capital-return profile for this ticker.

Performance

AIM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns AIM?

Insider, institutional, and short-interest positioning.

Institutional ownership

+1.7%

Float: +98.0% of shares outstanding

Insider ownership

+2.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

AIM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

30.0

Below 30: short-term oversold

Price vs 200-day MA

-80.0%

50/200-day relationship not available

Beta (5Y)

1.24

More volatile than the market

Sharpe ratio

-1.67

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About AIM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current AIM stock rating?

AIM ImmunoTech Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full AIM analysis?

The full report lives at /stocks/AIM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for AIM?

The latest report frames AIM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the AIM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.